Novartis Whistleblower Speaks: ‘We Wasted Money’
October 1, 2010
Nolan Auerbach’s clients’ case was part of the recent $422 million recovery from Novartis. The firm granted Pharmalot an exclusive interview with one of its clients. “[M]anagement would say you couldn’t use someone [for the speakers bureau] if they didn’t write a lot [of prescriptions for Novartis products], even if the person was an authority,” said Novartis whistleblower Jeremy Garrity. Three of the key whistleblowers in this case were represented by Nolan Auerbach.